akhatri

National Patient Safety Alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk National Patient Safety Alert Reference Number:  NatPSA/2025/002/UKHSA Date of issue: 26/06/2025 Explanation of identified safety issue UKHSA is investigating an outbreak of Burkholderia stabilis involving individuals across the UK, linked to wipes. Following testing, Burkholderia [...]

The post National Patient Safety Alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) Drug alert number: EL(25)A/29 Date issued: 25 June 2025 A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct [...]

The post MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) appeared first on Community Pharmacy England.

UPDATE  (15/04/2026) to communication (MSN/2025/036U) issued on 14 August 2025. Levemir® products are being discontinued. Stock exhaustion is expected in December 2026. This notification is being re-issued, as a high number of patients remain on Levemir® products. Healthcare professionals are reminded to switch patients on Levemir® to a suitable alternative as soon as possible. Patients [...]

The post Updated Medicine Supply Notification: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton. [...]

The post MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) appeared first on Community Pharmacy England.

Community Pharmacy England would like to remind pharmacy owners of the requirement to submit their FP34C declaration using the Manage Your Service (MYS) portal and to dispatch any prescription bundles to the relevant pricing division at the NHS Business Services Authority (NHSBSA) no later than the 5th day of the month following that in which [...]

The post Reminder: Submit your FP34C declaration and prescription bundles on time appeared first on Community Pharmacy England.